Historical record - last NADAC effective date: 8/21/2024

Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by BluePoint Laboratories, priced at $0.0963 per EA under NDC 68001038703. Its NADAC has been published 225 times since May 13, 2020.

FDA first approved this application on Sep 23, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB

Triamterene and Hydrochlorothiazide
$0.0963per EA

Strength

25; 37.5 mg/1; mg/1

NDC

68001038703

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/21/2024

Approval Type

Generic (ANDA)

FDA Application

ANDA073449

FDA Approved

9/23/1993

TE Code

AB

On Market Since

6/18/2019

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 225 times since May 13, 2020, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0963 per EA
All-time high$0.1187 (Aug 11, 2021)
All-time low$0.0794 (Apr 17, 2024)
Median price$0.0979
Average price$0.0984
Largest weekly change+23.5% (Jun 19, 2024)
Weeks tracked225
Tracking sinceMay 13, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+5.4%

5Y

-12.6%

All

-9.4%

Last surveyed Aug 28, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by BluePoint Laboratories, is $0.0963 per EA (NDC 68001038703), effective Aug 28, 2024.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 9.4%. It has been tracked across 225 weekly CMS publications since May 13, 2020.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Since May 13, 2020, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0794 (Apr 17, 2024) to a high of $0.1187 (Aug 11, 2021), with a median of $0.0979 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0954 per EA — about 1% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 68001038703) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.